Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients

Results Follow ACTIVATE Study Data In December

 
• By Alaric DeArment
  
3-D Rendering Red Blood Cells
Agios' trial of mitapivat shows reduction in transfusion burden among patinets with rare anemia. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip